Trial
NCT01144169
Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pittsburgh
Collaborators
National Institutes of Health (NIH)
Condition
Renal Cell Carcinoma
Intervention
Hydroxychloroquine (HC)
Why stopped
barriers to accrual: delay until surgery and additional pre-operative visits
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-26